Abstract
Last week, the National Institute on Drug Abuse (NIDA) issued a press release accompanying its study, co‐sponsored with the Centers for Disease Control and Prevention (CDC), which showed that flexibilities in buprenorphine prescribing did not lead to more fatal overdoses involving buprenorphine (see story, page 4).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have